dr. trent on the role of ctdna in soft tissue sarcoma
Published 4 years ago • 233 plays • Length 0:54
Download video MP4
Download video MP3
Similar videos
-
1:06
dr. trent on research efforts in bone and soft tissue sarcomas
-
2:40
analysis of patients with no baseline ctdna in the intrigue trial
-
1:30
dr. trent on sequencing trabectedin for patients with soft tissue sarcoma
-
0:55
jonathan trent on trabectedin for soft tissue sarcoma
-
1:09
dr. jonathan trent on t- cell therapy in sarcoma
-
22:20
dr. trent on the impact of covid-19 on the treatment of rare cancers
-
8:20
trabectedin in soft tissue sarcoma
-
1:16
dr. jonathan trent on fda approval of trabectedin for soft tissue sarcomas
-
3:28
dr. jonathan trent, identification of genetic alterations by circulating tumor dna in leiomyosarcoma
-
0:54
jonathan c. trent, md, phd: clinical data supporting the use of trabectedin
-
12:01
debate: is circulating tumor dna ready to guide adjuvant therapy in colon cancer? - yes
-
9:41
practices across expert sarcoma centers
-
2:28
circulating tumor dna (ctdna) in breast cancer: 2023 coeds ft lauderdale conference
-
7:41
case study: recurrent synovial sarcoma
-
3:22
dr. sanjay bagaria: sarcoma - mayo clinic
-
1:28
jonathan c. trent, md, phd: principle treatment goals for this patient
-
1:07
jonathan c. trent, md, phd: standard of care for invasive, unresectable leiomyosarcoma
-
2:29
dr. beltran on use of ctdna to evaluate treatment resistance in prostate cancer
-
1:00
jonathan c. trent, md, phd: pattern of this patient’s metastatic disease
Clip.africa.com - Privacy-policy